Výsledky vyhledávání - "N. Mody-Patel"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Relationship between compliance, costs, hospitalizations for CML and GIST patients using imatinib mesylate

Autor: Denise Williams, N. Mody-Patel, Victoria Barghout, R. Halpern

Publikováno v: Journal of Clinical Oncology. 26:6598-6598

6598 Background: Imatinib mesylate is an oral tyrosine kinase inhibitor dosed daily for treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumor (GIST). The relationships between imatinib compliance and costs and inpatient hospi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a0e752c6a5180f571ee524913c25e1b
https://doi.org/10.1200/jco.2008.26.15_suppl.6598

Zobrazit plný text záznamu

Reflecting time dependency in hazard rates to analyse the cost-effectiveness of letrozole or anastrozole versus tamoxifen as adjuvant therapies for early breast cancer in hormone receptor-positive (HR+) postmenopausal women: The U.S. perspective

Autor: S. Kaura, N. Mody-Patel, Jonathan Karnon

Publikováno v: Journal of Clinical Oncology. 26:596-596

596 Background: The BIG 1–98 and ATAC randomized controlled trials demonstrated that, in postmenopausal women with hormone receptor-positive (HR+) early breast cancer, initial adjuvant therapy for 5 years with the aromatase inhibitors (AIs) letrozo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::060246e6635af14480b93b55f642e647
https://doi.org/10.1200/jco.2008.26.15_suppl.596

Zobrazit plný text záznamu

Zoledronic acid compliance and persistency in bone metastases due to breast, lung, and prostate cancer

Autor: James C. Jackson, T. Gondesen, N. Mody-Patel, Mansoor N. Saleh, V. Barghout, Bruce A. Feinberg, James Gilmore

Publikováno v: Journal of Clinical Oncology. 26:17513-17513

17513 Background: The purpose of this study was to assess medication compliance and persistency in breast, lung, and prostate cancer patients with bone metastases receiving Zoledronic acid (ZOL) in...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::853cc24843597ffbab804caa5efe3184
https://doi.org/10.1200/jco.2008.26.15_suppl.17513

Zobrazit plný text záznamu

The impact of zoledronic acid treatment on frequency of skeletal complications experienced and on followup duration post diagnosis of bone metastasis in lung cancer patients

Autor: Allan Lipton, Hind T. Hatoum, Matthew R. Smith, Victoria Barghout, Swu-Jane Lin, N. Mody-Patel

Publikováno v: Journal of Clinical Oncology. 26:8106-8106

8106 Background: Lung cancer patients (pts) with bone metastasis are at high risk for skeletal complications (SCs). These SCs greatly compromise the patients’ quality of life, survival and add grea...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6a3d91d7e94787ac139569b14087b79a
https://doi.org/10.1200/jco.2008.26.15_suppl.8106

Zobrazit plný text záznamu

Cost associated with distant, contralateral, and local-regional breast cancer recurrence in a vertically integrated health care system

Autor: D. Wiederkehr, S. Kaura, N. Mody-Patel, Lee Stern, Augustina Ogbonnaya

Publikováno v: Journal of Clinical Oncology. 26:1141-1141

1141 Background: Breast cancer is associated with considerable health care resource utilization and patients who experience recurrent breast cancer require more costly care than patients who do not develop recurrent disease. Research has also shown t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eb6b600832c32d5bd75d78a0063c0499
https://doi.org/10.1200/jco.2008.26.15_suppl.1141

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání